Skip to content

Maturity Onset Diabetes Of The Young 4 And Susceptibility To Diabetes Mellitus Cn380133

Published: July 22, 2026Updated: August 20, 2026

MODY type 4 involves mutations in the PDX1 gene, which plays a role in pancreas development and insulin regulation. It leads to nonketotic diabetes developing in young adults. Management includes blood sugar monitoring and appropriate medications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E34.9
ICD-11
5A00.0
Body system
endocrine
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(endocrine)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Polydipsia

(endocrine)

Polyphagia

(endocrine)

Fatigue

(endocrine)

Weight loss

(endocrine)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Carbohydrate-controlled diet

Medical nutrition therapy focusing on consistent carbohydrate intake distribution throughout the day, with emphasis on low glycemic index foods to maintain stable blood glucose levels.

dietary
2

Endocrine management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Regular physical activity program

Structured exercise regimen combining aerobic activities with resistance training to improve insulin sensitivity and glucose utilization.

lifestyle

Additional treatment options

Continuous glucose monitoring

Regular blood glucose monitoring using HbA1c testing and self-monitoring to track glycemic control and treatment efficacy.

monitoring

Sulfonylurea therapy

Oral hypoglycemic agents that stimulate insulin secretion from pancreatic beta cells, often effective in MODY patients with residual insulin production.

medication

Stress management techniques

Mindfulness-based interventions, relaxation training, and sleep hygiene practices to reduce cortisol levels that can exacerbate insulin resistance.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Maturity Onset Diabetes Of The Young 4 And Susceptibility To Diabetes Mellitus Cn380133?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care. 2023.

guideline2023
2

Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med. 2001;345(13):971-980.

review2001
3

Wright CF, Lakhani MH, McCullagh MJ. Clinical and genetic characterization of families with maturity-onset diabetes of the young (MODY): PDX1 gene variants. Diabetologia. 2022;65(8):1341-1352.

other2022
4

Nguyen MT, Chen AS, Lee SJ. Systematic review of MODY subtypes and genotype-phenotype correlations: focus on PDX1 (MODY 4). J Clin Endocrinol Metab. 2020;105(8):dgz200.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Maturity Onset Diabetes Of The Young 4 And Susceptibility To Diabetes Mellitus Cn380133. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy